# Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor

> **NCT03667092** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 47 (actual)

## Conditions studied

- Midgut Neuroendocrine Tumors

## Interventions

- **BIOLOGICAL:** non-drug intervention type

## Key facts

- **NCT ID:** NCT03667092
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2024-05-22
- **Final completion:** 2024-05-22
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03667092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03667092, "Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03667092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*